(Q46427141)

22 December 2017

title

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates (English)

1 reference

22 December 2017

1 reference

Edwin H Preston

1

1 reference

22 December 2017

He Xu

2

1 reference

22 December 2017

Kiran K Dhanireddy

3

1 reference

22 December 2017

Jonathan P Pearl

4

1 reference

22 December 2017

Frank V Leopardi

5

1 reference

22 December 2017

Matthew F Starost

6

1 reference

22 December 2017

Douglas A Hale

7

1 reference

22 December 2017

Allan D Kirk

8

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

American Journal of Transplantation

published in

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

1032-1041

1 reference

22 December 2017

Infection in solid organ transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Immunotherapy as a means to induce transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

T-cell costimulatory pathways in allograft rejection and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

The role of CD154 in organ transplant rejection and acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

The CD40 pathway in allograft rejection, acceptance, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

The CD154-CD40 costimulatory pathway in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Anti-CD40 therapy extends renal allograft survival in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Heterologous immunity provides a potent barrier to transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40–CD40L signalling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00796.X

10.1111/J.1600-6143.2005.00796.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017